刊物主题:Internal Medicine; Metabolic Diseases; Human Physiology;
出版者:Springer Berlin Heidelberg
ISSN:1432-0428
卷排序:60
文摘
Aims/hypothesisTo overcome the donor shortage in the treatment of advanced type 1 diabetes by islet transplantation, human embryonic stem cells (hESCs) show great potential as an unlimited alternative source of beta cells. hESCs may have immune privileged properties and it is important to determine whether these properties are preserved in hESC-derived cells.